THE Christie Hospital has unveiled its latest equipment in its battle against cancer - a hi-tech machine that allows experts to carry out research into cancer-causing genes.

The Quantative Polymerase Chain Reaction (PAR) machine was bought after members of the Christie Hospital Women's Trust Fund raised the £80,000 needed.

The machine will allow scientists at the hospital to test both normal and cancerous cells for certain genes, enabling them to work out which genes are responsible for the development of cancer. This will lead to earlier diagnosis and better treatments. Members of the Women's Trust Fund at the Christie have raised more than £4 million since it was formed in 1948.

Christie appeals director Toni Leden said: "They have a long tradition of supporting Christie's and their enthusiasm is as strong as ever."

Trust Fund members have visited the hospital to see the equipment in action.

Now they are hoping to raise £53,000 for an isolator for Christie's radiopharmacy, which will provide staff and patients with protection from radioactive products used in cancer treatment.